{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Denver",
      "state": "CO",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97779",
      "recalling_firm": "STAQ Pharma, Inc.",
      "address_1": "14135 E 42nd Ave Ste 50",
      "address_2": "",
      "postal_code": "80239-5214",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the U.S.",
      "recall_number": "D-0023-2026",
      "product_description": "Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.",
      "product_quantity": "",
      "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date",
      "recall_initiation_date": "20251009",
      "center_classification_date": "20251015",
      "report_date": "20251022",
      "code_info": "Lot #: 25104595A, Expiry: 27DEC2025.",
      "more_code_info": ""
    }
  ]
}